AI assistant
EDAP TMS SA — Director's Dealing 2026
Jan 14, 2026
34258_dirs_2026-01-14_9f475b2e-ada9-4384-8dc1-6576805ebc17.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: EDAP TMS SA (EDAP)
CIK: 0001041934
Period of Report: 2026-01-01
Reporting Person: Rhodes Ryan (Director, Chief Executive Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 301149 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $6.57 | 2031-06-11 | Common Stock (800000) | Direct | |
| Stock Options | $11.87 | 2033-05-02 | Stock Options (200000) | Direct | |
| Stock Options | $8.03 | 2034-03-26 | Stock Options (100000) | Direct | |
| Stock Options | $1.42 | 2035-04-15 | Stock Options (500000) | Direct |
Footnotes
F1: Includes restricted stock units ("RSUs") granted pursuant to the 2025 RSU (Free Share) Plan of the Company on June 20, 2025. Each RSU represents the right to receive one share of EDAP common stock, four-sixths of which will vest on the second anniversary of the date of grant and the remaining two-sixths will vest in two installments on December 20, 2027 and on June 20, 2028, respectively.
F2: The options, which were granted on June 11, 2021, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F3: The option exercise price reflected was converted from 5.59 euros to U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
F4: The options, which were granted on May 2, 2023, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F5: The option exercise price reflected was converted from 10.10 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
F6: The options, which were granted on March 26, 2024, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F7: The option exercise price reflected was converted from 6.83 euros to U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
F8: The options, which were granted on April 15, 2025, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
F9: The option exercise price reflected was converted from 1.21 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.